News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Immunotope, Inc. Awarded A US Army Phase II Contract To Develop Prostate Cancer Early Detection Test


10/23/2006 2:42:04 PM

Doylestown, PA (PRWEB) October 20, 2006 -- Immunotope, Inc. a biotechnology company developing cancer diagnostics and immunotherapeutics, has been awarded a Phase II SBIR contract from the US Army to develop an autoantibody-based early-stage diagnostic test for prostate cancer. The two-year, $780,000 award will fund the development of a noninvasive, highly sensitive and selective blood test.

Read at PRWEB

comments powered by Disqus
PRWEB
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES